June 28, 2012 — The following is being released today by the Cincinnati Children's Hospital Medical Center:
New research ...
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
June 28, 2012 — The following is being released today by the Cincinnati Children's Hospital Medical Center:
New research ...
June 25, 2012 — Clinical investigators are for the first time examining the retrograde tibiopedal interventional ...
June 25, 2012 — St. Jude Medical Inc. today commented on the Durata lead failure reported in the MAUDE database report ...
June 22, 2012 — In a recently approved position statement, the American Association of Physicists in Medicine (AAPM) ...
June 22, 2012 –– The U.S. Food and Drug Administration (FDA) recently selected a stent graft being developed by ...
June 21, 2012 — Plans for a new study involving BioFreedom, the polymer-free drug-coated stent (DCS) from Biosensors ...
June 20, 2012 — In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the ...
June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety ...
June 15, 2012 — CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self ...
June 13, 2012 — Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the ...
June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) ...
June 11, 2012 — An estimated 85.3 million computed tomography (CT) procedures were performed in 8,465 hospital and non ...
June 8, 2012 — Children and young adults scanned multiple times by computed tomography (CT) have a small increased risk ...
June 8, 2012 — Austin Heart, the largest provider of cardiac and vascular services in central Texas, announced its ...
May 30, 2012 — Tryton Medical Inc., the leading developer of stents designed to definitively treat bifurcation lesions ...